These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6396559)

  • 21. Lipoproteins of the crystalline lens and serum factors in senile cataract.
    Goswamy S; Mathur RL; Agarwal LP
    Indian J Med Res; 1971 Sep; 59(9):1460-6. PubMed ID: 5161574
    [No Abstract]   [Full Text] [Related]  

  • 22. [Like anticataract agents, the antiaggregants of lens crystallin. Communication 2. Study of the impact of chaperon-like (protective) activity of short-chain peptides on the rate of UV-induced aggregation of betaL-crystallins by eximer laser].
    Soustov LV; Chelnokov EV; Sapogova NV; Bitiurin NM; Nemov VV; Karpova OE; Sheremet NL; Polunin GS; Avetisov SE; Ostrovskiĭ MA
    Vestn Oftalmol; 2008; 124(2):6-8. PubMed ID: 18488460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products.
    Saxena P; Saxena AK; Cui XL; Obrenovich M; Gudipaty K; Monnier VM
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1473-81. PubMed ID: 10798665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Conservative management of senile cataract with conjunctisan A eye drops].
    Fuchs J
    Klin Monbl Augenheilkd; 1979 Dec; 175(6):799-805. PubMed ID: 552005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of short-range protein interactions in lens opacifications.
    Ponce A; Sorensen C; Takemoto L
    Mol Vis; 2006 Aug; 12():879-84. PubMed ID: 16917488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular ions, protein metabolism, and cataract formation.
    Piatigorsky J
    Curr Top Eye Res; 1980; 3():1-39. PubMed ID: 7047087
    [No Abstract]   [Full Text] [Related]  

  • 27. Proteomic analysis of water insoluble proteins from normal and cataractous human lenses.
    Harrington V; Srivastava OP; Kirk M
    Mol Vis; 2007 Sep; 13():1680-94. PubMed ID: 17893670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-related cataract and drug therapy: opportunities and challenges for topical antioxidant delivery to the lens.
    Abdelkader H; Alany RG; Pierscionek B
    J Pharm Pharmacol; 2015 Apr; 67(4):537-50. PubMed ID: 25643848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Quinax preparation in conservative treatment of senile cataract (author's transl)].
    Jabłoński J; Pankowska B
    Klin Oczna; 1980 Apr; 82(4):219-20. PubMed ID: 7431800
    [No Abstract]   [Full Text] [Related]  

  • 30. NMR analyses of the cold cataract. II. Studies on protein solutions.
    Lerman S; Megaw JM; Gardner K; Ashley D; Long RC; Goldstein JH
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):99-105. PubMed ID: 6826319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-crystallin complexes exist in the water-soluble high molecular weight protein fractions of aging normal and cataractous human lenses.
    Srivastava K; Chaves JM; Srivastava OP; Kirk M
    Exp Eye Res; 2008 Oct; 87(4):356-66. PubMed ID: 18662688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on azapentacene, anti-cataract agent (author's transl)].
    Fukushi S; Suzuki T
    Nippon Ganka Gakkai Zasshi; 1981 Jan; 85(1):37-43. PubMed ID: 7258001
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experimental basis for using preparations with antioxidant action in treating senile cataract].
    Pliushko DG; Voskresenskaia LK
    Oftalmol Zh; 1985; (7):386-8. PubMed ID: 4088558
    [No Abstract]   [Full Text] [Related]  

  • 34. [Age-related cataract: etiopathogenesis and drug treatment].
    Polunin GS; Sheremet NL; Karpova OE
    Vestn Oftalmol; 2007; 123(4):48-51. PubMed ID: 17802764
    [No Abstract]   [Full Text] [Related]  

  • 35. Calcium activated proteolysis and protein modification in the U18666A cataract.
    Chandrasekher G; Cenedella RJ
    Exp Eye Res; 1993 Dec; 57(6):737-45. PubMed ID: 8150025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The lens and cataract in diabetes.
    Bron AJ; Brown NA; Harding JJ; Ganea E
    Int Ophthalmol Clin; 1998; 38(2):37-67. PubMed ID: 9604737
    [No Abstract]   [Full Text] [Related]  

  • 37. [Conservative treatment potentials in initial senile cataract].
    Larionov LN
    Vestn Oftalmol; 1980; (5):49-51. PubMed ID: 7423731
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of MPG on glucocorticoid-induced cataract formation in developing chick embryo.
    Nishigori H; Hayashi R; Lee JW; Iwatsuru M
    Invest Ophthalmol Vis Sci; 1984 Sep; 25(9):1051-5. PubMed ID: 6469489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes in water-soluble, urea-soluble and membrane intrinsic proteins in human senile cataract].
    Zhao HR; Hu SQ; Ren XH
    Zhonghua Yan Ke Za Zhi; 1994 May; 30(3):186-8. PubMed ID: 7842996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the pyridoindole antioxidant stobadine on development of experimental diabetic cataract and on lens protein oxidation in rats: comparison with vitamin E and BHT.
    Kyselova Z; Gajdosik A; Gajdosikova A; Ulicna O; Mihalova D; Karasu C; Stefek M
    Mol Vis; 2005 Jan; 11():56-65. PubMed ID: 15682043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.